MPR, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient outcomes.

The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...

A Tandem pump built for (Type) 2: President and CEO John Sheridan said the company's expansion was a "natural evolution" of its mission. (Tandem Diabetes Care) Tandem Diabetes Care has secured a new ...

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

A landmark study by the German Diabetes Center (DDZ), published in The Lancet Diabetes & Endocrinology, sheds new light on the heterogeneity of type 2 diabetes. The researchers have employed an ...

T2DM is a major risk factor for CHD. In recent years, machine learning algorithms have demonstrated significant advantages in improving predictive accuracy; however, studies applying these methods for ...

Dietary changes are helpful in managing type 2 diabetes, but you don’t have to change everything all at once. A recent diagnosis of type 2 diabetes may leave you feeling overwhelmed. There’s a lot of ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...